Inflation, declining FDA drug approvals will pose challenges for pharma CMOs in 2023: GlobalData EP News Bureau Apr 7, 2023 GlobalData’s latest report reveals that the FDA’s NME approvals declined substantially in 2022, causing overall NDA approvals to…
